Arcline Investment Management Invests in Dark Horse Consulting Group
July 30, 2019
Arcline Investment Management made a growth investment in Dark Horse Consulting Group to support the company's expansion of cGMP products and services for the cell and gene therapy industry. The capital commitment is intended to accelerate Dark Horse's ability to meet rising client demand across manufacturing, regulatory, and CMC consulting.
- Buyers
- Arcline Investment Management
- Targets
- Dark Horse Consulting Group
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Growth capital
Explore More
Related Acquisitions
-
WestView Capital Partners Makes Growth Investment in Dark Horse Consulting Group
October 4, 2022
Healthcare Services
Boston-based growth equity firm WestView Capital Partners has completed a growth investment in Dark Horse Consulting Group (DHC), a Walnut Creek, California–based consultancy specializing in cell and gene therapy (CGT) CMC and regulatory strategy. The investment will support DHC's continued growth and expansion of its service offerings and global team, and WestView principals will join DHC's board.
-
Dark Horse Consulting Group Acquires Converge Consulting
September 18, 2025
Consulting
Dark Horse Consulting Group (DHCG), a global strategic and operational consulting firm focused on cell and gene therapy and biotherapeutics, has acquired Converge Consulting, LLC, a Cambridge-based life sciences consulting firm. The acquisition expands DHCG's capabilities in supply chain, manufacturing, commercial launch readiness, enterprise IT solutions, CMC, and Quality to provide broader end-to-end support across the product development lifecycle.
-
Dark Horse Consulting Group Acquires BioTechLogic, Inc.
October 3, 2024
Consulting
Dark Horse Consulting Group (DHC), a WestView Capital Partners–backed consulting platform, has acquired BioTechLogic, Inc., a CMC, manufacturing, quality and regulatory consulting firm serving biopharma and advanced therapies. The deal combines BioTechLogic's hands-on technical operations expertise with DHC's strategic CGT capabilities to expand service offerings across biologics, vaccines and cell & gene therapy clients.
-
Dark Horse Consulting Group Acquires Bruder Consulting & Venture Group
January 9, 2026
Consulting
Dark Horse Consulting Group (DHCG) has acquired Bruder Consulting & Venture Group (BCVG), integrating BCVG as a Regenerative Medicine department within DHC to expand the group's capabilities in regenerative medicine, tissue repair, and biomaterials. The deal brings BCVG's strategic advisory expertise in discovery, development, clinical design, and regulatory affairs into DHCG's global consulting platform.
-
Arcline Investment Management Makes Strategic Investment in American Casting Company
December 2, 2025
Aerospace & Defense
Arcline Investment Management, a growth-oriented private equity firm, completed a strategic investment in American Casting Company (ACC), a Hollister, California-based provider of engineered investment castings for aerospace, defense, medical and energy applications. ACC will continue to be led by CEO Chris St. John; Arcline plans to support expansion of the company’s capabilities and capacity to meet rising demand from OEMs reshoring mission‑critical components. Janes Capital Partners served as financial advisor to the company.
-
Jones Capital Recapitalizes Dark Horse Electric
July 31, 2024
Utilities
Jones Capital completed a recapitalization of Dark Horse Electric, a Sunbright, Tennessee-based provider of vegetation management and power line construction services for utilities and public-sector customers. The transaction will provide growth capital and operational support to expand Dark Horse's service capabilities and geographic reach while the company continues to operate from its Sunbright headquarters.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.